Cynthia L. Garber
Cynthia L. Garber is a nurse attorney at Robinson Calcagnie, Inc., where she focuses her practice on wrongful death and catastrophic personal injury pharmaceutical and medical device product liability litigation. Ms. Garber’s extensive medical knowledge, coupled with her trial experience and public speaking background, has proven invaluable to her in the practice of pharmaceutical and medical device mass tort litigation.
Before becoming an attorney, Ms. Garber was employed as a registered nurse for 12 years, during which time she gained vast experience in the areas of critical cardiac and emergency care, and nursing education.
As part of her legal education, Ms. Garber did a Judicial Externship with the Honorable David G. Sills, Presiding Justice, Court of Appeal of the State of California, Division Three. She then began her legal career, receiving her initial litigation experience at Lopez, Hodes, Restaino, Milman & Skikos, where she practiced in the areas of Medical Malpractice, Elder Abuse and Pharmaceutical Mass Torts.
Ms. Garber has participated in every aspect of trial preparation and has participated as “first chair” in a number of medical malpractice cases. Most notably, she was a member of the Robinson Calcagnie trial team for a talcum powder case against Johnson & Johnson that results in a $417 million verdict. Ms. Garber worked closely with key gynecologic oncologist, toxicologists and epidemiologist and took numerous pre-trial depositions. She was also awarded the prestigious 2018 CLAY award as an attorney of the year for extraordinary achievement in 2017 in Toxic Torts. In addition to the $417 million verdict, she served as trial team member for a Vioxx case again Merck & Co., Inc that resulted in a $51 million verdict. Ms. Garber has also been involved in personal injury trials and settlements totaling over $100 million. One of those settlements is one of the highest settlement amounts for an orthopedic injury.
Due to her extensive medical background, Ms. Garber has been appointed to numerous plaintiff steering committees in mass tort litigation that manage complex multi-district litigation arising from pharmaceutical drug and medical device defects. She has been appointed to MDL and state coordinated proceedings and on national science subcommittees, at times serving as the scientific chair. Her scientific expertise has allowed Ms. Garber to take national depositions of large pharmaceutical corporation witnesses.
Ms. Garber has also been invited to speak on many occasions for various groups, including lawyer associations, mass tort science committees and conferences where she has given lectures on the science and risk factors involved with many pharmaceutical drugs and medical devices. Ms. Garber has testified before the Food and Drug Administration (FDA) regarding proposal of labeling changes for approved drugs and biologic products. Her awards and honors include the AV Preeminent Peer Review Rating through LexisNexis Martindale Hubbell; The Nation’s Top One Percent, National Association of Distinguished Counsel, Southern California Super Lawyers 2014-2016; Top 50: 2015-2016 Women Southern California Super Lawyers – Top List; Avvo.com Superb Score 10 out of 10; Rising Star, 2008; and listed, The Bar Register of Preeminent Lawyers; and The Bar Register of Preeminent Women Lawyers.
Ms. Garber grew up in Newport Beach‚ California. She attended San Diego State University from 1978 to 1982. She received her Associate of Science degree in 1985 from Loma Linda University in Nursing, and became a Registered Nurse in January 1986. She earned her Juris Doctorate, Cum Laude from Western State College of Law, Fullerton, CA in 1999‚ and was admitted to the California Bar in 2000. She was also admitted to the United States District Court for the Central District of California in 2000, and the United States Supreme Court in 2005.